Cite
HARVARD Citation
Collinson, F. et al. (n.d.). 931TiPPRISM: A randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma. Annals of oncology. p. . [Online].